Dare Bioscience
DARE
31 hedge funds and large institutions have $12.8M invested in Dare Bioscience in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 7 closing their positions.
275% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 4
41% more capital invested
Capital invested by funds: $9.12M → $12.8M (+$3.71M)
0.04% more ownership
Funds ownership: 0.73% → 0.77% (+0.04%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less funds holding
Funds holding: 36 → 31 (-5)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$324K |
| 2 |
FFS
Founders Financial Securities
Towson,
Maryland
|
+$280K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$119K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$77K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$64.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$311K |
| 2 |
FFA
Founders Financial Alliance
Raleigh,
North Carolina
|
-$126K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$41.2K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$40K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
26
HRT Financial
New York
| $13K | +$15.8K | +1,147 | New |
|
|
IA
27
IFS Advisors
Overland Park,
Kansas
| $11K | – | – | – |
|
28
Wells Fargo
San Francisco,
California
| $11K | +$9.15K | +666 | +311% |
|
29
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $4K | +$1.15K | +84 | +30% |
|
|
APA
30
American Portfolios Advisors
Holbrook,
New York
| $1K | – | – | – |
|
|
FFA
31
Founders Financial Alliance
Raleigh,
North Carolina
| – | -$126K | -8,542 | Closed |
|
|
GCP
32
GSA Capital Partners
London,
United Kingdom
| – | -$40K | -2,696 | Closed |
|
|
XT
33
XTX Topco
George Town,
Cayman Islands
| – | -$23K | -1,571 | Closed |
|
|
CSS
34
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$21K | -1,403 | Closed |
|
35
Victory Capital Management
San Antonio,
Texas
| – | -$14K | -952 | Closed |
|
|
HNWAG
36
High Net Worth Advisory Group
Naples,
Florida
| – | -$1K | -83 | Closed |
|
|
AWA
37
Artemis Wealth Advisors
New York
| – | -$1.08K | -73 | Closed |
|
38
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$14 | +1 | New |
|
DARE Hedge Fund Activity: Q3 2022 in Review
31 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q3 2022, worth a combined $12.8M — up 41% from $9.12M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of DARE and 2 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 15 added.
The largest buyer was Renaissance Technologies, adding an estimated $324K. The largest seller was Millennium Management, cutting an estimated $311K.
- 31 institutional investors held Dare Bioscience (DARE) as of Q3 2022, down from 36 in Q2 2022.
- Funds reported $12.8M of Dare Bioscience stock for Q3 2022, up 41% quarter-over-quarter.
- 2 funds opened new Dare Bioscience positions in Q3 2022 and 7 closed out, a net change of -5 holders.
- The largest Dare Bioscience buyer in Q3 2022 was Renaissance Technologies, an estimated $324K added.
- The largest Dare Bioscience seller in Q3 2022 was Millennium Management, an estimated $311K sold.
Based on aggregated 13F filings for Q3 2022.